| Literature DB >> 35295547 |
Vrinda Kalia1, Daniel W Belsky2, Andrea A Baccarelli1, Gary W Miller1.
Abstract
The exposome, the environmental complement of the genome, is an omics level characterization of an individual's exposures. There is growing interest in uncovering the role of the environment in human health using an exposomic framework that provides a systematic and unbiased analysis of the non-genetic drivers of health and disease. Many environmental toxicants are associated with molecular hallmarks of aging. An exposomic framework has potential to advance understanding of these associations and how modifications to the environment can promote healthy aging in the population. However, few studies have used this framework to study biological aging. We provide an overview of approaches and challenges in using an exposomic framework to investigate environmental drivers of aging. While capturing exposures over a life course is a daunting and expensive task, the use of historical data can be a practical way to approach this research.Entities:
Keywords: aging; exposome; hallmarks of aging; measuring the exposome; population-based studies of aging
Year: 2022 PMID: 35295547 PMCID: PMC8917275 DOI: 10.1093/exposome/osac002
Source DB: PubMed Journal: Exposome ISSN: 2635-2265
Figure 1.A selection of environmental exposures and hallmarks of aging. The nine hallmarks of aging represent common mechanisms of biological aging in the mammalian context. The inner most gray circle illustrates these hallmarks of aging. In the outer circle, icons represent environmental exposures that have been associated with each corresponding hallmark of aging. Each category can comprise of multiple exposures and are grouped due to similarity in: source, use, chemical structure or properties, or associated health effects. Created with BioRender.com
Figure 2.Data sources for exposure assessment. For each exposure that has been associated with hallmarks of aging listed in the first column, the corresponding source of exposure data is represented by icons along the row. Created with BioRender.com
A selection of population-based studies of aging well-suited to investigate the exposome
| Resource | Location/cohort | Tissue type/biomarkers | Environmental data | Sample size/age range | Reference |
|---|---|---|---|---|---|
| Gateway to global aging data | US Health and Retirement Study; Mexican Health and Aging Study; English Longitudinal Study of Ageing; Study of Health, Ageing and Retirement in Europe; Costa Rican Longevity and Healthy Aging Study; Korea Employment Information Service; Japanese Study of Aging and Retirement; The Irish Longitudinal study of Ageing; The China Health and Retirement Longitudinal Study; The Longitudinal Study in India; Malaysia Ageing and Retirement Survey; Health, Aging, and Retirement in Thailand; The Brazilian Longitudinal Study of Aging; Northern Ireland Cohort for the Longitudinal study of Ageing; Healthy Ageing in Scotland; The Health and Aging Study in Africa; Study on Global Ageing and Adult Health; Indonesia Family Life Survey | Varies by cohort. The reader is encouraged to visit this resource for information: | Residential address, questionnaires |
The sample size varies by cohort and ranges from ∼3000 to ∼70 000 at baseline. The age eligibility varies by cohort and ranges from 40 to 60 years. |
|
| Centre for Longitudinal Studies | 1958 National Child Development Study, 1970 British Cohort Study, Next Steps, Millennium Cohort Study | Blood | Questionnaires |
The sample size varies by cohort but ranges from 16 000 to 19 000. The age varies by cohort. |
|
| The UK Household Longitudinal Study | United Kingdom | Blood | Questionnaires |
In Wave 1, surveyed 40 000 households. Includes people of all ages. | [ |
| The Rotterdam Study | Netherlands | Blood | Questionnaires |
Sample size of 15 000. Age > 45 years. | [ |
| The Leiden Longevity Study | Netherlands | Blood | Questionnaires |
Surveyed 421 families. Age criteria ≥89 for men and ≥91 for women |
[ |
| The Lothian Birth Cohorts | United Kingdom | Blood | Questionnaires |
The two birth cohorts had an initial (Wave 1) sample size of 550 and 1091. Age > 69 years | [ |
| Cooperative Health Research in the Augsburg Region (KORA) | Germany | Blood | Geospatial data, questionnaires |
Sample size of 18 000. Age range 25–74 years | [ |
| The European Prospective Investigation into Cancer and Nutrition | Europe | Blood | Questionnaires |
Sample size of 521 000. Age range 35–70 years |
[
|
| Longitudinal Aging Study Amsterdam, GECCO, and MINDMAP study | Netherlands | Blood | Geo-coded data, questionnaires |
Initial sample size of 3805. Age range 55–84 years | [ |
| Jerusalem Longitudinal study | Israel | Blood, serum, urine | Residential address, questionnaires |
Initial sample size of 605 Representative of those 70-years old. | [ |
| Cambridge city over 75 s cohort | United Kingdom | Blood and saliva | Residential address, questionnaires |
Sample size 2600 Age > 75 years | [ |
| Cognitive Function and Aging studies | United Kingdom | Blood | Residential address, questionnaires |
Sample size >18 000 Age >65 years | [ |
| GAZEL cohort | France | – | Occupational exposure, residential address, questionnaires |
Sample size >20 000 Age >35 years | [ |
| Helsinki Health study | Finland | – | Occupational exposure, residential address, questionnaires |
Sample size >9000 Age range 40–60 years | [ |
| All of us Research Program | United States | Blood, saliva, urine | Wearable sensors, residential address, questionnaires, EHR |
Aim to enroll at least 1 million people Age >18 years | [ |
| UK Biobank | United Kingdom | Blood, saliva, urine | Wearable devices, residential address, questionnaires, EHR |
Sample size of 500 000 Age >40 years | [ |
| Washington Heights and Inwood Community Aging Project | United States | Blood | Residential address, questionnaires |
Sample size >4000 Age >65 years | [ |
| Multi-Ethnic Study of Atherosclerosis (MESA) and MESA Air | United States | Blood | Residential address, air pollution estimates, questionnaires |
Sample size of 6814 Age range 45–84 at enrollment | [ |
| Mediators of Atherosclerosis in South Asians Living in America | United States | Blood, urine | Residential address, questionnaires |
Sample size of 906 Age range 40–79 at enrollment | [ |
| The London Life Sciences Prospective Population Study | United Kingdom | Blood | Residential address, questionnaires |
Sample size ∼28 000 Age range 35–74 at enrollment | [ |
| Normative Aging Study | United States | Blood | Residential address, questionnaires |
Initial sample size of 2280 Mean age at enrollment 42 years | [ |
| Women’s health initiative | United States | Blood | Residential address, questionnaires |
Sample size >161 000 Age at enrollment 50–79 years | [ |
| Strong Heart Study | United States | Blood, urine | Questionnaires |
Sample size >7600 Age at enrollment 35–74 years | [ |
| Baltimore Longitudinal Study of Aging | United States | Blood, urine | Residential address, questionnaires |
Sample size >3200 Age >20 years at enrollment | [ |
| Coronary Artery Risk Development in Young Adults Study | United States | Blood, urine | Residential address, questionnaires |
Sample size >5000 Age at enrollment 18–30 years | [ |
| Rush Memory and Aging Project | United States | Blood | Residential address, questionnaires |
Initial sample size 1556 Mean age ∼81 years | [ |
Many population studies of aging exist that can be used to study environmental drivers of aging using an exposomic framework. A selection of them are shown here. GECCO, Geoscience and Health Cohort Consortium and GAZEL, GAZ and ELectricité.